rdf:type |
|
lifeskim:mentions |
umls-concept:C0011777,
umls-concept:C0162522,
umls-concept:C0199176,
umls-concept:C0205195,
umls-concept:C0209210,
umls-concept:C0439841,
umls-concept:C0542559,
umls-concept:C1274040,
umls-concept:C1280500,
umls-concept:C1547135,
umls-concept:C1547139,
umls-concept:C1561560,
umls-concept:C1561561
|
pubmed:issue |
6
|
pubmed:dateCreated |
2002-8-9
|
pubmed:abstractText |
Postoperative nausea and vomiting after laparoscopic cholecystectomy remains a common problem despite routine antiemetic prophylaxis. Therefore, the authors investigated the effect of administering 4 mg intravenous dexamethasone as an adjunct to a 5-HT3 antagonist (12.5 mg intravenous dolasetron) with respect to patient outcome.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0003-3022
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
96
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1346-50
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12170046-Adult,
pubmed-meshheading:12170046-Aged,
pubmed-meshheading:12170046-Antiemetics,
pubmed-meshheading:12170046-Cholecystectomy, Laparoscopic,
pubmed-meshheading:12170046-Dexamethasone,
pubmed-meshheading:12170046-Double-Blind Method,
pubmed-meshheading:12170046-Drug Therapy, Combination,
pubmed-meshheading:12170046-Female,
pubmed-meshheading:12170046-Humans,
pubmed-meshheading:12170046-Indoles,
pubmed-meshheading:12170046-Male,
pubmed-meshheading:12170046-Middle Aged,
pubmed-meshheading:12170046-Postoperative Nausea and Vomiting,
pubmed-meshheading:12170046-Prospective Studies,
pubmed-meshheading:12170046-Quinolizines,
pubmed-meshheading:12170046-Treatment Outcome
|
pubmed:year |
2002
|
pubmed:articleTitle |
Dexamethasone in combination with dolasetron for prophylaxis in the ambulatory setting: effect on outcome after laparoscopic cholecystectomy.
|
pubmed:affiliation |
Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390-9068, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|